Zhang Na, Sun Zhen-zhu, Li Feng, Cao Yu-wen, Zhao Chun-xia, Liang Wei-hua, Sun Hua-peng, Li Hong-an, Fu Xin-ge
Department of Pathology, Shihezi University School of Medicine, Shihezi 832002, China.
Zhonghua Bing Li Xue Za Zhi. 2011 May;40(5):324-9.
To explore the relevance between the promoter methylation status of Notch1 gene and the invasive ductal carcinoma and ductal hyperplastic lesions of the breast.
Methylation status of Notch1 gene in human breast invasive ductal carcinoma (IDC, n = 89), ductal carcinoma in situ (DCIS, n = 20), atypical ductal hyperplasia (ADH, n = 11) and usual ductal hyperplasia (UDH, n = 20) were quantitatively evaluated by MALDI-TOF MS. The expression of Notch1 protein was detected by immunohistochemical stain (SP method).
Positive expression rates of Notch1 protein in IDC and DCIS were 91.0% (81/89) and 75.0% (15/20), respectively, which were significantly higher than those of ADH (4/11) and UDH (30.0%, 6/20;P < 0.05). Notch1 protein expression was correlated significantly with lymph node metastasis, pathological grades and TNM stages of IDC. The mean methylation levels of Notch1 gene at CpG_3, CpG_4.5 and CpG_8 significantly decreased in IDC group compared with those of DCIS, ADH and UDH groups (P < 0.0083). In breast carcinomas, the mean methylation rates of Notch1 gene at CpG_4.5, CpG_10.11, and CpG_14.15.16 loci in cases with axillary node metastasis were significantly lower than those without axillary node metastasis (P < 0.05); and the methylation rates at CpG_14.15.16 and CpG_18 loci in stage Iwere lower than that in stage II, further lower than that in stage III (P < 0.05); and that in CpG_1.2, CpG_12.13 loci in grade I (highly-differentiated group) were higher than that in grade II (moderate-differentiated group) and grade III (poorly-differentiated group) (P < 0.05); and the methylation rates at CpG_3, CpG_8 and CpG_14.15.16 loci in ER(+) PR(+) HER2(-) group were lower than that in ER(-) PR(-) HER2(+) group (P < 0.05).
There is an overall hypomethylation of Notch1 gene in breast invasive ductal carcinomas with corresponding over-expression of Notch1 protein. This inverse correlation show that the alteration of protein expression result from hypomethylation oncogene Notch1, and this change may have important significance in breast tumorigenesis and the development. Specific hypomethylation at CpG_3, CpG_ 4.5 and CpG_8 loci of Notch1 gene may play a role in the pathogenesis of breast carcinoma, suggesting the progression and/or malignant transformation from benign glandular lesions of the breast.
探讨Notch1基因启动子甲基化状态与乳腺浸润性导管癌及导管增生性病变的相关性。
采用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)定量评估人乳腺浸润性导管癌(IDC,n = 89)、导管原位癌(DCIS,n = 20)、非典型导管增生(ADH,n = 11)和普通导管增生(UDH,n = 20)中Notch1基因的甲基化状态。采用免疫组织化学染色(SP法)检测Notch1蛋白的表达。
Notch1蛋白在IDC和DCIS中的阳性表达率分别为91.0%(81/89)和75.0%(15/20),显著高于ADH(4/11)和UDH(30.0%,6/20;P < 0.05)。Notch1蛋白表达与IDC的淋巴结转移、病理分级和TNM分期显著相关。与DCIS、ADH和UDH组相比,IDC组中Notch1基因在CpG_3、CpG_4.5和CpG_8位点的平均甲基化水平显著降低(P < 0.0083)。在乳腺癌中,有腋窝淋巴结转移病例的Notch1基因在CpG_4.5、CpG_10.11和CpG_14.15.16位点的平均甲基化率显著低于无腋窝淋巴结转移者(P < 0.05);I期患者在CpG_14.15.16和CpG_18位点的甲基化率低于II期,II期又低于III期(P < 0.05);I级(高分化组)患者在CpG_1.2、CpG_12.13位点的甲基化率高于II级(中分化组)和III级(低分化组)(P < 0.05);ER(+) PR(+) HER2(-)组中Notch1基因在CpG_3、CpG_8和CpG_14.15.16位点的甲基化率低于ER(-) PR(-) HER2(+)组(P < 0.05)。
乳腺浸润性导管癌中Notch1基因总体呈低甲基化状态,伴有Notch1蛋白相应过表达。这种负相关表明Notch1癌基因低甲基化导致蛋白表达改变,且这种变化可能在乳腺肿瘤发生和发展中具有重要意义。Notch1基因在CpG_3、CpG_4.5和CpG_8位点的特异性低甲基化可能在乳腺癌发病机制中起作用,提示乳腺良性腺性病变的进展和/或恶性转化。